Cargando…
Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial
BACKGROUND: To report the long-term outcomes of a phase III trial designed to test two hypotheses: (1) elective nodal irradiation (ENI) is superior to conventional field irradiation (CFI), and (2) chemoradiotherapy plus erlotinib is superior to chemoradiotherapy in locally advanced oesophageal squam...
Autores principales: | Xie, Congying, Jing, Zhao, Luo, Honglei, Jiang, Wei, Ma, Li, Hu, Wei, Zheng, Anping, Li, Duojie, Ding, Lingyu, Zhang, Hongyan, Xie, Conghua, Lian, Xilong, Du, Dexi, Chen, Ming, Bian, Xiuhua, Tan, Bangxian, Xia, Bing, Xie, Ruifei, Liu, Qing, Wang, Lvhua, Wu, Shixiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686329/ https://www.ncbi.nlm.nih.gov/pubmed/32958820 http://dx.doi.org/10.1038/s41416-020-01054-6 |
Ejemplares similares
-
Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy
por: Xie, Congying, et al.
Publicado: (2019) -
Icotinib With Concurrent Radiotherapy vs Radiotherapy Alone in Older Adults With Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Randomized Clinical Trial
por: Luo, Honglei, et al.
Publicado: (2020) -
T4/N2 classification nasopharyngeal carcinoma benefit from concurrent chemotherapy in the era of intensity-modulated radiotherapy
por: Xie, Ruifei, et al.
Publicado: (2016) -
Long‐term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer
por: Jing, Zhao, et al.
Publicado: (2017) -
Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
por: Wu, Shixiu, et al.
Publicado: (2015)